Table 2.
Clinical features of chronically A. xylosoxidans-infected patients (case group) compared with the control group
| Chronically infected patients by A. xylosoxidans (n = 6) | Chronically infected patients by P. aeruginosa (n = 6) | p-value | |||||
|---|---|---|---|---|---|---|---|
| −1 year | Time0 | +1 year | −1 year | Time0 | +1 year | ||
| Mean age | 10.5 | 11.5 | 12.5 | 11.1 | 12.1 | 13.1 | >0.05 |
| BMI | 16.9 | 17.8 | 18.2 | 16.8 | 17.3 | 17.4 | >0.05 |
| Mean FEV1 (%) (range) | 66.5% (33.6–86%) | 62% (33.6–79%) | 61.7% (34.8–76%) | 63.% (45.2–99%) | 63.2% (38.4–99%) | 63.7% (38.4–97%) | >0.05 |
| P. aeruginosa co-colonization (no. of patients) | 6 | 6 | 6 | – | – | – | |
| CFRD (no. of patients) | 1 | 1 | 3 | 1 | 3 | 4 | >0.05 |
CFRD = cystic fibrosis-related diabetes